Option Care Health, Inc. $OPCH Position Increased by Jennison Associates LLC

Jennison Associates LLC grew its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 4.2% during the first quarter, Holdings Channel reports. The firm owned 1,213,025 shares of the company’s stock after acquiring an additional 49,094 shares during the quarter. Jennison Associates LLC’s holdings in Option Care Health were worth $32,655,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Durable Capital Partners LP boosted its holdings in shares of Option Care Health by 134.2% in the 2nd quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after buying an additional 4,720,988 shares during the period. Southpoint Capital Advisors LP acquired a new stake in Option Care Health during the fourth quarter worth about $95,580,000. Sumitomo Mitsui Trust Group Inc. acquired a new stake in Option Care Health during the first quarter worth about $70,287,000. Norges Bank acquired a new stake in Option Care Health during the fourth quarter worth about $61,787,000. Finally, Alyeska Investment Group L.P. bought a new position in Option Care Health in the fourth quarter worth about $38,559,000. 98.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

OPCH has been the subject of several recent research reports. TD Cowen lowered their target price on Option Care Health from $37.00 to $23.00 and set a “hold” rating for the company in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $26.00 price target on shares of Option Care Health in a report on Friday, May 1st. The Goldman Sachs Group assumed coverage on Option Care Health in a research note on Monday, June 8th. They set a “neutral” rating and a $22.00 price objective for the company. Stephens reaffirmed an “equal weight” rating and issued a $24.00 target price (down from $30.00) on shares of Option Care Health in a research report on Friday. Finally, Bank of America cut Option Care Health from a “buy” rating to a “neutral” rating and set a $22.00 target price on the stock. in a research note on Friday, May 1st. Eight equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $30.08.

Option Care Health Price Performance

Shares of NASDAQ:OPCH opened at $21.75 on Tuesday. The firm’s 50 day moving average is $21.19 and its two-hundred day moving average is $27.39. The firm has a market capitalization of $3.42 billion, a P/E ratio of 16.86, a PEG ratio of 1.21 and a beta of 0.65. The company has a current ratio of 1.64, a quick ratio of 1.07 and a debt-to-equity ratio of 0.85. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.39 billion. During the same period in the previous year, the firm posted $0.40 earnings per share. The business’s revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Analysts anticipate that Option Care Health, Inc. will post 1.64 earnings per share for the current year.

Insider Buying and Selling at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 36,610 shares of the firm’s stock in a transaction dated Monday, May 4th. The stock was bought at an average price of $21.41 per share, with a total value of $783,820.10. Following the completion of the purchase, the director owned 450,000 shares in the company, valued at $9,634,500. This trade represents a 8.86% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO John Charles Rademacher purchased 12,500 shares of the stock in a transaction dated Monday, May 4th. The shares were acquired at an average cost of $21.18 per share, for a total transaction of $264,750.00. Following the completion of the acquisition, the chief executive officer directly owned 695,152 shares of the company’s stock, valued at approximately $14,723,319.36. This trade represents a 1.83% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 73,264 shares of company stock valued at $1,548,316 in the last quarter. Corporate insiders own 1.70% of the company’s stock.

Option Care Health Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.